APA (7th ed.) Citation

Chua, C., Mahamed, D., Nkongolo, S., Sanchez Vasquez, J. D., Mehrotra, A., Wong, D. K. H., . . . Gehring, A. J. (2024). Liver-restricted type I IFN signature precedes liver damage in chronic hepatitis B patients stopping antiviral therapy. The journal of immunology, 212(6), . https://doi.org/10.4049/jimmunol.2300569

Chicago Style (17th ed.) Citation

Chua, Conan, et al. "Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy." The Journal of Immunology 212, no. 6 (2024). https://doi.org/10.4049/jimmunol.2300569.

MLA (9th ed.) Citation

Chua, Conan, et al. "Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy." The Journal of Immunology, vol. 212, no. 6, 2024, https://doi.org/10.4049/jimmunol.2300569.